Feline Dysbiosis Index: interpreting chronic enteropathy patients

Chronic enteropathy in cats may present as persistent diarrhoea, vomiting, poor body condition or weight loss. Possible causes include food-responsive disease, inflammatory bowel disease, infection, neoplasia and extragastrointestinal disorders. Faecal microbiome testing can add useful context by showing whether microbial organisation has shifted alongside the clinical syndrome.

The Feline Dysbiosis Index provides a standardised way to place faecal sequencing findings against feline reference data. It is most useful as an adjunct to clinical assessment and becomes particularly valuable when results are tracked over time in the same patient.

What the index measures

A microbiome index compresses complex sequencing data into an interpretable signal. Reports may combine within-sample alpha diversity, differences between samples, individual taxon abundance and inferred microbial functions. The index is not a simple count of beneficial and harmful bacteria.

Dysbiosis describes an altered microbial ecosystem. Changes can involve reduced diversity, expansion of particular organisms, loss of resident taxa and altered metabolic potential. No single feature defines it, so the overall report and sample quality matter more than one highlighted organism.

The index should also be distinguished from disease severity. A marked shift may accompany active inflammation, while a smaller change can still matter in a cat losing weight. A result close to the reference range does not exclude a significant extragastrointestinal cause of vomiting.

Why microbial patterns matter

Different enteropathies can produce partly overlapping microbial patterns. Diet, intestinal transit, bile-acid handling and mucosal inflammation all influence resident organisms, while vomiting and altered faecal consistency change the material being sampled.

These overlaps explain why microbiome data cannot establish a histologic diagnosis. Results can support a clinical hypothesis, prioritise further investigation and indicate whether treatment has shifted the ecosystem toward or away from the reference pattern.

Interpretation should consider what else changed around collection. Medication, diet, outdoor access, stress and stool transit can all influence a sample. A sudden shift after antibiotics or a new food may represent a temporary ecological response rather than progression of the original disease.

Establishing a reliable baseline

A baseline is strongest when collected before therapy whenever this can be done safely. Dehydration and severe metabolic disturbance should be addressed first, and urgent treatment should never wait for microbiome sequencing.

Record faecal consistency, transit time, recent medication, diet, parasite control and concurrent illness. Where practical, use the same laboratory, collection method and reporting period, because preservation, DNA extraction and reference populations can affect apparent diversity and classification.

For cats in regional Australia, courier conditions and warm temperatures may affect sample transit. Collection and dispatch instructions therefore deserve close attention, even when the laboratory is located interstate.

Interpreting serial results

Serial results answer a more useful question than a single snapshot: is the cat moving in the same direction as its clinical response? Compare the overall index, the features driving the result and objective outcomes such as weight, appetite, stool score and cobalamin status.

Age also shapes the expected microbiome. Evidence on age-related microbiome shifts in senior dogs is not a feline study, yet it illustrates why an abnormal older-cat sample should be interpreted against age-appropriate reference data rather than a universal adult profile.

A stable score does not guarantee remission, and a fluctuating score need not indicate treatment failure. Look for a coherent pattern across time and clinical measures before deciding whether further testing or treatment adjustment is justified.

Accounting for diet and treatment

Dietary modification, cobalamin support and other treatments can affect microbial composition. For cats, a planned trial using a highly digestible, appropriate-fat or hydrolysed-protein diet should follow the clinical diagnosis and nutritional assessment, with the household’s established feeding pattern considered.

A canine study of fat-level comparisons demonstrates why dietary variables deserve attention, although its findings cannot be transferred directly to cats. Document nutrient changes and avoid judging microbial movement while several dietary variables are changing simultaneously.

Antimicrobials, anti-inflammatory drugs, laxatives and acid suppression may also alter the sample. Their effects complicate interpretation, yet withholding necessary treatment solely to preserve a baseline is rarely appropriate. Record timing and allow the clinical course to stabilise before drawing firm conclusions.

Australian clinical realities

Australian lifestyles shape feline exposures. In Sydney, Melbourne and Brisbane, many cats live in apartments or small suburban homes, using balconies, catios or managed outdoor time. Feeding routines, litter conditions, household stress and reduced fibre intake can affect faecal patterns, making lifestyle history relevant to sequencing results.

Outdoor access in regional areas creates different risks, including parasite exposure and contact with environmental contaminants. Persistent diarrhoea should be assessed alongside faecal testing and parasite control rather than attributed to dysbiosis alone. Cat containment requirements differ across states and local councils, making containment status and outdoor access useful clinical details.

The local pet-food market includes veterinary clinics, supermarkets, pet shops and online sellers, with access to therapeutic diets varying between metropolitan and regional practices. Prescription veterinary medicines are regulated through the Australian Pesticides and Veterinary Medicines Authority, so owners should obtain them through an authorised veterinary channel.

Applying findings in practice

Use the index within a structured review. Combine it with history, body-weight trends, examination, bloodwork, faecal analysis, cobalamin and folate testing when indicated, and imaging or tissue diagnosis when disease remains unclear. The result should inform the next clinical decision rather than become the decision itself.

Set review points before treatment begins, after meaningful clinical change and during reassessment. Consider whether the microbiome and patient are improving together, and whether a result is being driven by a manageable factor such as a recent diet change. This keeps interpretation longitudinal and clinically proportionate.

Veterinary teams can access the related on-demand webinar, expert presentations and downloadable resources through the Hill’s ActivBiome education library, with participation certificates available for completed activities. The programme has been presented in partnership with researchers and institutions including Harvard T.H. Chan School of Public Health, Texas A&M University and the University of Vienna. Used with appropriate clinical context, dysbiosis findings can clarify microbial change without allowing a microbiome label to outrun the evidence from the patient.